JANX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Janux Therapeutics dosed the first patient in the Phase 1 JANX013 trialSep 14, 2026
- Janux Therapeutics dosed the first patient in a Phase 1 study of JANX011Feb 17, 2026
- Janux announced encouraging efficacy and safety profile from ongoing Phase 1 clinical trial for JANX007 in metastatic castration-resistant prostate cancerDec 2, 2025
- Janux Therapeutics highlights pipeline progress and best-in-class potential of novel bispecific platform for autoimmune diseases at virtual R&D dayJul 25, 2025